Byosen Limited
Biosensing intelligence for behavioral health risk management.
| Date | Investors | Amount | Round |
|---|---|---|---|
£250k | Seed | ||
| Total Funding | 000k | ||
Byosen Limited is a technology company specializing in software and biotechnology for the healthcare sector. Incorporated on May 10, 2021, the firm aims to address the predictability and management of behavioral health risks for payers, providers, and government entities. Byosen helps insurance companies and healthcare providers integrate biosensing intelligence feedback into their care management programs and treatment monitoring. This approach is designed to mitigate rising costs, improve patient outcomes, and reduce the burden on care resources.
The company was founded by Margot Blanc, who serves as the CEO. Blanc holds a BA with honours in Business Innovation and Entrepreneurship from Greenwich University and has prior experience as a Business Analyst at the venture capital fund Angelcube. She is part of the Deep Tech team of the Founders Program at the Station F incubator. The company's advisory board includes professionals with extensive experience in medical product development, biochemical sensors, and the management of human aging.
Byosen is classified under Other software publishing and Research and experimental development on biotechnology. The company's registered office is in London, England.
Keywords: biosensing intelligence, behavioral health, risk management, care management, treatment monitoring, healthtech, insurtech, biotechnology, predictive analytics, patient outcomes, digital health, medical diagnostics, biochemical sensors, physiological monitoring, healthcare data, preventative care, chronic disease management, remote patient monitoring, wearable technology, health insurance